“Fighting Fraud and Scams Targeting Older Americans,” a hearing held June 24, 2022 (witness statements available in .pdf format, video of the full hearing available at the site, running time hour minutes).
www.aging.senate.gov/hearings/fighting-fraud-and-scams-targeting-older-americans
A. “Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional),” (PAS-22-196, a reissue of PAS-19-316, National Institute on Aging, in conjunction with other agencies, application deadline Jan. 5, April 5, and Sept. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional),” (PAS-22-197).
grants.nih.gov/grants/guide/pa-files/PAS-22-196.html
B. “Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed),” (RFA-AG-23-033, National Institute on Aging, application deadline Oct. 21, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-033.html
Powered by WordPress
